Now that Donald Trump’s “Devin Nunes memo” stunt has failed, even most of his allies are either distancing themselves from it, or simply trying to move on. But Trump never met a lost battle he didn’t want to obsess over. Now that Nunes’ credibility is completely gone and he’s become a national punchline, Trump is making a point of aligning himself with Nunes, while viciously attacking Nunes’ House Intel Committee counterpart, Adam Schiff. It isn’t exactly going well for him.
Trump woke up from his crypt this morning and tweeted “Little Adam Schiff, who is desperate to run for higher office, is one of the biggest liars and leakers in Washington, right up there with Comey, Warner, Brennan and Clapper! Adam leaves closed committee hearings to illegally leak confidential information. Must be stopped!” The good news for Trump: his tweet prompted “Little Adam Schiff” to become a top trending topic across social media. The bad news for Trump: it wasn’t trending for the reason he was hoping, as Americans rushed in to make fun of Trump over it.
The pushback from all sides began immediately. Adam Parkhomenko from the Hillary Clinton campaign responded by tweeting “If you don’t think Trump will end up in prison, you are probably insane too.” The scorn was bipartisan in nature, as Republican strategist Rick Wilson took aim at Trump’s tweet by calling him “President Ragetweet McProjection.”
John Fugelsang went for the jugular, tweeting: “‘Heh, heh. I got ‘Little Adam Schiff’ to trend nationwide. I win.’ But by 11am that dopamine rush had ended, & the 71-year old was trying to decide on call girls, firing those investigating him, or armed conflict to provide his next make-brain-happy-this-instant-fix.” Congresswoman Karen Bass went on CNN and stated that “This is the President of the United States … It’s an embarrassment on the international stage.”
Help support Palmer Report. We're often days, weeks or months ahead of the mainstream media on important political storylines – just ask our longtime readers. You can follow us on Facebook and Twitter, or sign up for our mailing list.